We confirmed that these GD_Tumor cells were CD2 + , CD3 + , CD4-, CD5-, CD7 + and CD8, CD38, CD56 (NCAM1) partial positive, aligned with the diagnostic guidelines (Fig. S3) [4, 6]. This evidence concerns the gene CD2 and neoplasm.